These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16023084)

  • 1. Neurocognitive profile in adolescents with early-onset schizophrenia: clinical correlates.
    Rhinewine JP; Lencz T; Thaden EP; Cervellione KL; Burdick KE; Henderson I; Bhaskar S; Keehlisen L; Kane J; Kohn N; Fisch GS; Bilder RM; Kumra S
    Biol Psychiatry; 2005 Nov; 58(9):705-12. PubMed ID: 16023084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
    Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
    Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects.
    White T; Ho BC; Ward J; O'Leary D; Andreasen NC
    Biol Psychiatry; 2006 Sep; 60(5):463-71. PubMed ID: 16566898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive deficits in adolescents with schizophrenia: longitudinal stability and predictive utility for short-term functional outcome.
    Cervellione KL; Burdick KE; Cottone JG; Rhinewine JP; Kumra S
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):867-78. PubMed ID: 17581451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.
    Bilder RM; Goldman RS; Robinson D; Reiter G; Bell L; Bates JA; Pappadopulos E; Willson DF; Alvir JM; Woerner MG; Geisler S; Kane JM; Lieberman JA
    Am J Psychiatry; 2000 Apr; 157(4):549-59. PubMed ID: 10739413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.
    Swerdlow NR; Light GA; Cadenhead KS; Sprock J; Hsieh MH; Braff DL
    Arch Gen Psychiatry; 2006 Dec; 63(12):1325-35. PubMed ID: 17146007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
    Sánchez-Morla EM; Barabash A; Martínez-Vizcaíno V; Tabarés-Seisdedos R; Balanzá-Martínez V; Cabranes-Díaz JA; Baca-Baldomero E; Gómez JL
    Psychiatry Res; 2009 Oct; 169(3):220-8. PubMed ID: 19758705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.
    Reilly JL; Harris MS; Keshavan MS; Sweeney JA
    Arch Gen Psychiatry; 2006 Nov; 63(11):1189-97. PubMed ID: 17088499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The connection between mentalization deficit and pragmatic language skills and neurocognition in schizophrenia].
    Herold R; Tényi T; Simon M; Trixler M
    Neuropsychopharmacol Hung; 2004 Jun; 6(2):72-8. PubMed ID: 15787204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological profile of cognitively impaired patients with schizophrenia.
    Bozikas VP; Kosmidis MH; Kiosseoglou G; Karavatos A
    Compr Psychiatry; 2006; 47(2):136-43. PubMed ID: 16490572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?
    Varga M; Magnusson A; Flekkøy K; David AS; Opjordsmoen S
    Compr Psychiatry; 2007; 48(6):583-91. PubMed ID: 17954145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychologic functioning in autism: profile of a complex information processing disorder.
    Minshew NJ; Goldstein G; Siegel DJ
    J Int Neuropsychol Soc; 1997 Jul; 3(4):303-16. PubMed ID: 9260440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up.
    Tabarés-Seisdedos R; Balanzá-Martínez V; Sánchez-Moreno J; Martinez-Aran A; Salazar-Fraile J; Selva-Vera G; Rubio C; Mata I; Gómez-Beneyto M; Vieta E
    J Affect Disord; 2008 Aug; 109(3):286-99. PubMed ID: 18289698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficits in neurocognition, theory of mind, and social functioning in patients with schizophrenic disorders: are they related?
    Bâ MB; Zanello A; Varnier M; Koellner V; Merlo MC
    J Nerv Ment Dis; 2008 Feb; 196(2):153-6. PubMed ID: 18277224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalized and specific neurocognitive deficits in prodromal schizophrenia.
    Lencz T; Smith CW; McLaughlin D; Auther A; Nakayama E; Hovey L; Cornblatt BA
    Biol Psychiatry; 2006 May; 59(9):863-71. PubMed ID: 16325151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
    Bozikas VP; Kosmidis MH; Giannakou M; Anezoulaki D; Petrikis P; Fokas K; Karavatos A
    J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S; Dias VV; Carita AI; Martinez-Arán A
    Psychiatry Res; 2008 Jul; 160(1):55-62. PubMed ID: 18485488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia.
    Pukrop R; Schultze-Lutter F; Ruhrmann S; Brockhaus-Dumke A; Tendolkar I; Bechdolf A; Matuschek E; Klosterkötter J
    J Clin Exp Neuropsychol; 2006 Nov; 28(8):1388-407. PubMed ID: 17050266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.